Data as of Apr 17
| +0.55 / +1.43%|
The 18 analysts offering 12-month price forecasts for Abbott Laboratories have a median target of 42.00, with a high estimate of 46.00 and a low estimate of 36.00. The median estimate represents a +7.89% increase from the last price of 38.93.
The current consensus among 26 polled investment analysts is to Buy stock in Abbott Laboratories. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.